Expensify to Announce Q1 2025 Results
- 74
Expensify, Inc. (Nasdaq: EXFY), a payments superapp that helps individuals and businesses around the world simplify the way they manage money across expenses, corporate cards, travel and bills, today announced that the company’s Q1 2025 financial results will be released after market close on Thursday, May 8th, 2025.
Expensify will host a call to discuss its Q1 on Thursday, May 8th, 2025 at 2pm PT / 5pm ET. The link to the call will be available that day on the company’s Investor Relations website at investors.expensify.com. Prior to the call, interested parties can visit the website to add the event to their calendars.
After the call, the following will be made available at investors.expensify.com:
- A full recording of the call
- An investor deck and press release summarizing financial results
To get started using Expensify or to learn more, head over to use.expensify.com.
About Expensify
Expensify helps 15 million people worldwide track expenses, book travel, reimburse employees, manage corporate cards, send invoices, and pay bills—all in one place. Whether you're self-employed, running a small business, managing a team, or overseeing global finances, let Expensify handle your travel and expense, at the speed of chat.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250424530343/en/
- JoAcademy Partners With Truecaller to Deliver Trusted, Contextual Communication Experience for the Student Ecosystem in Jordan
- DEA Crushes Illegal Marijuana - But Still Blocks MMJ's Legal Cannabis Drug for Huntington's
- ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS
- ROSEN, A RANKED AND LEADING LAW FIRM, Encourages 3D Systems Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - DDD
- WK KELLOGG INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of WK Kellogg Co - KLG
- VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc - VRNA